Instil Bio (TIL) Capital Expenditures (2020 - 2026)
Instil Bio (TIL) posted quarterly Capital Expenditures of -$80000.0 for Q1 2026, little changed year-over-year from -$80000.0 in Q1 2025, and little changed quarter-over-quarter from -$80000.0 in Q4 2025.
Instil Bio (TIL) Capital Expenditures (2020 - 2026) Analysis & Trends
Instil Bio's Capital Expenditures history runs 7 years deep, the most recent figure standing at -$80000.0 for Q1 2026.
- In Q1 2026, Capital Expenditures changed 0.0% year-over-year to -$80000.0; the TTM figure through Mar 2026 stood at -$425000.0 (down 110.4% YoY), while the FY2025 annual figure was -$425000.0, down 109.74% from the prior year.
- Capital Expenditures for Q1 2026 stood at -$80000.0, roughly flat from -$80000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $20.9 million in Q4 2023, with the low at -$9.0 million in Q2 2022.
- The 5-year median for Capital Expenditures is $197000.0 (2024), against an average of $2.2 million.
- The sharpest annual moves came in 2023 and 2025: Capital Expenditures soared 905.31% in 2023, then slumped 225.88% in 2025.
- Instil Bio's Capital Expenditures stood at -$2.6 million in 2022, then jumped by 905.31% to $20.9 million in 2023, then slumped by 94.04% to $1.2 million in 2024, then sank by 106.41% to -$80000.0 in 2025, then changed by 0.0% to -$80000.0 in 2026.
- Business Quant data shows TIL's Capital Expenditures at -$80000.0 in Q1 2026, -$80000.0 in Q4 2025, and -$2.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 25.02 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 34.68 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -73.57 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.26 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 251.02 Mn |
| 10 | Instil Bio | 51.68 Mn | 51.68 Mn | - | -80,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -80,000.00 |
| Jun 30, 2026 | -80,000.00 |
| Mar 31, 2026 | -80,000.00 |
| Mar 31, 2026 | -80,000.00 |
| Dec 31, 2025 | -80,000.00 |
| Dec 31, 2025 | -80,000.00 |
| Sep 30, 2025 | -2.79 Mn |
| Sep 30, 2025 | -2.79 Mn |
| Jun 30, 2025 | 2.52 Mn |
| Jun 30, 2025 | 2.52 Mn |
| Mar 31, 2025 | -80,000.00 |
| Mar 31, 2025 | -80,000.00 |
| Dec 31, 2024 | 1.25 Mn |
| Dec 31, 2024 | 1.25 Mn |
| Sep 30, 2024 | 2.21 Mn |
| Sep 30, 2024 | 2.21 Mn |
| Jun 30, 2024 | 704,000.00 |
| Jun 30, 2024 | 704,000.00 |
| Mar 31, 2024 | 197,000.00 |
| Mar 31, 2024 | 197,000.00 |